Key result
Regional STEMI registry shows 8.8% 1-month mortality, remaining higher than other registries despite strict criteria.
Why the study?
Different mortality rates are reported in STEMI registries, but comparisons are challenging; the authors sought to determine whether higher mortality in a regional French registry reflects differing inclusion criteria and demographic characteristics.
Observational (n=1,501)
Yes
Differences in reported STEMI mortality rates between registries are heavily influenced by variations in inclusion criteria and demographic characteristics, highlighting the need for harmonization.
Answers are grounded in this paper and cite their sources.
Caution against direct STEMI mortality comparisons across registries without standardized criteria; supports harmonization while leaving unmeasured confounders open.
Background Different mortality rates are reported in registries of patients with ST-segment elevation myocardial infarction (STEMI), but comparisons between registries are challenging.Aims To determine whether the higher mortality rate in our regional French registry (SCALIM) is related to different inclusion criteria and demographic characteristics.Methods The SCALIM registry included all patients with STEMI within the first 24 h in the region of Limousin, France (06/2011–01/2015). To compare mortality rates with other contemporary registries in France and European neighbouring countries, the others’ inclusion criteria were applied to the SCALIM registry.Results Among 1501 patients included, in-hospital and 1-month mortality were 8.2% and 8.8% respectively, significantly higher than many other registries. The use of inclusion criteria from EMUST (France), MINAP (UK) or LOMBARDIMA (Italy) markedly decreased the number of enrolled patients by 64%, 36%, and 21%, respectively. When those inclusion criteria were applied to the SCALIM registry, difference in in-hospital and 1-month mortality rates between other registries and ours remained significant. In the multivariate analysis, age, initial acute pulmonary oedema (Killip class ≥2), complication occurring before percutaneous coronary intervention, absence of transfer to an interventional cardiology centre for primary angioplasty and lack of reperfusion therapy within 12 h were associated with higher risk of 1-month mortality (all p < 0.05). Age (65 versus 63.3 years, p < 0.001) was higher and reperfusion rate (84.2 versus 74.7%, p < 0.001) was significantly lower in SCALIM than FAST-MI, the national French registry on STEMI patients. Interestingly, the 3% of patients included in SCALIM who would be excluded from FAST-MI registry had 91% mortality at one month.Conclusion Higher mortality rate in our regional SCALIM registry is in part due to differences in inclusion criteria and demographic data. Consensus should be made to harmonise inclusion criteria in STEMI registries for the sake of comparability.
No takes yet. Share an insight, caveat, or question.
Martins et al. (2021) conducted an observational in ST-segment elevation myocardial infarction (STEMI) (n=1,501). Broad regional registry inclusion (all STEMI within 24h) vs. Stricter inclusion criteria from other contemporary registries was evaluated on In-hospital and 1-month mortality. In a regional registry of 1,501 STEMI patients, 1-month mortality was 8.8%, which remained significantly higher than other registries even when applying their stricter inclusion criteria.
Synapse has enriched 10 related papers. Consider them for comparative context: